AMBER CORNEILLIE: Open Payments
NPI 1033187265 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 9 payments from 8 companies in 2025. Trend: 2023 $201 · 2024 $364 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $67 |
| PFIZER INC. | 1 | $58 |
| GENZYME CORPORATION | 2 | $54 |
| Genentech USA, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, Rhapsido, LITFULO, Xolair, ANZUPGO, Zoryve, OTEZLA.
Industry payments across MI — which companies pay providers there.
